Hypo-and Hyperthyroidism Affect the ATP, ADP and AMP Hydrolysis in Rat Hippocampal and Cortical Slices
Overview
Authors
Affiliations
The presence of severe neurological symptoms in thyroid diseases has highlighted the importance of thyroid hormones in the normal functioning of the mature brain. Since, ATP is an important excitatory neurotransmitter and adenosine acts as a neuromodulatory structure inhibiting neurotransmitters release in the central nervous system (CNS), the ectonucleotidase cascade that hydrolyzes ATP to adenosine, is also involved in the control of brain functions. Thus, we investigated the influence of hyper-and hypothyroidism on the ATP, ADP and AMP hydrolysis in hippocampal and cortical slices from adult rats. Hyperthyroidism was induced by daily injections of l-thyroxine (T4) 25 microg/100 g body weight, for 14 days. Hypothyroidism was induced by thyroidectomy and methimazole (0.05%) added to their drinking water for 14 days. Hypothyroid rats were hormonally replaced by daily injections of T4 (5 microg/100 g body weight, i.p.) for 5 days. Hyperthyroidism significantly inhibited the ATP, ADP and AMP hydrolysis in hippocampal slices. In brain cortical slices, hyperthyroidism inhibited the AMP hydrolysis. In contrast, hypothyroidism increased the ATP, ADP and AMP hydrolysis in both hippocampal and cortical slices and these effects were reverted by T4 replacement. Furthermore, hypothyroidism increased the expression of NTPDase1 and 5'-nucleotidase, whereas hyperthyroidism decreased the expression of 5'-nucleotidase in hippocampus of adult rats. These findings demonstrate that thyroid disorders may influence the enzymes involved in the complete degradation of ATP to adenosine and possibly affects the responses mediated by adenine nucleotides in the CNS of adult rats.
Yilmaz Oral D, Guven Ciloglu B, Gur S Urol Res Pract. 2025; 50(4):247-252.
PMID: 39873473 PMC: 11883669. DOI: 10.5152/tud.2025.24099.
Purinergic signaling in thyroid disease.
Le Y, Lu D, Xue M Purinergic Signal. 2022; 19(1):221-227.
PMID: 35347568 PMC: 9984614. DOI: 10.1007/s11302-022-09858-2.
Logue O, George E, Bidwell 3rd G Clin Sci (Lond). 2016; 130(16):1417-34.
PMID: 27389588 PMC: 4958371. DOI: 10.1042/CS20160108.
Purinergic signaling pathways in endocrine system.
Bjelobaba I, Janjic M, Stojilkovic S Auton Neurosci. 2015; 191:102-16.
PMID: 25960051 PMC: 4536093. DOI: 10.1016/j.autneu.2015.04.010.
New approaches to thyroid hormones and purinergic signaling.
Silveira G, Buffon A, Bruno A J Thyroid Res. 2013; 2013:434727.
PMID: 23956925 PMC: 3730180. DOI: 10.1155/2013/434727.